Press release
Coronary Stent Grafts Market Emerging Economies Expected to Influence Growth until 2028 // key player - Bentley Innomed GmbH, Abbott, Vascular Concepts, InSitu Technologies
Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1065
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still report issues associated with angina in follow-up time periods, which could increase the demand for cardiac medical treatments, which usually include coronary stent grafts. Furthermore, the growing number of ambulatory surgical centers, hospitals, medical facilities, and emergency rooms, etc. continue to increase sale prospects of coronary stent grafts, with each one of them needing the medical equipment required to perform treatment of severe perforation or rupture of coronary arteries and aneurysm of coronary arteries, etc.
A recent vital interventional cardiology prediction made by American College of Cardiology (ACC) and Transcatheter Cardiovascular Therapeutics (TCT) meetings indicates eventual monopoly of bioresorbable stents in the forthcoming years, which is expected to bring tremendous changes in the manufacturing of coronary stent grafts market, prompting the makers of coronary stent grafts to explore enhanced bioreasorable solution to be able to meet the changing needs of the medical practices.
Furthermore, coronary stent grafts market may remain highly influenced by the diverse rapidly-changing percutaneous coronary intervention (PCI) regulations, for example, the existing US guidelines don’t endorse elective PCI in facilities in the absence of on-site surgical back-up, which could impact coronary stent grafts market.
Stents are small expandable tubes used to treat narrowed or weakened arteries in the body. In patients with coronary artery disease (CAD), coronary stents are used to open narrowed arteries and also help in reducing symptoms, such as chest pain (angina), as well as in the treatment of heart attack. Coronary stent grafts are used for transluminal implantation in coronary arteries or aorto-coronary bypass grafts for the treatment of acute perforation or rupture of coronary arteries as well as aneurysm of coronary arteries or coronary bypass-vein graft. Coronary stents are implanted in narrowed coronary arteries during a procedure called the percutaneous coronary intervention (PCI) or angioplasty.
Coronary stent grafts are of various types, such as Bio-Vascular Scaffold (BVS), Bio-engineered Stent, Drug Eluting Stents (DES), Bare metal stents and Dual Therapy Stent (DTS). These different types of stents are used for various different purposes. The Bio-Vascular Scaffold (BVS) is a drug eluting stent on a dissolvable type of scaffold platform which can be absorbed by the body over time. A Bio-engineered Stent (antibody-coated stent), on the other hand, helps in speed up the cell lining of the artery (endothelialization), thereby promoting natural healing. The Drug Eluting Stents (DES) are coated with medication that is released (eluted) to help prevent the growth of scar tissue in the artery lining. This type of stent helps the artery to remain smooth and open, thereby ensuring good blood flow and reducing the chances of artery re-narrowing or restenosis. Bare metal stents are usually made from stainless steel and have no special coating.
Browse Full Report with TOC- https://www.factmr.com/report/1065/coronary-stent-grafts-market
Dual Therapy Stent (DTS) is the latest type of coronary stent. It is a first-of-its-kind stent therapy that reduces any likelihood of the re-narrowing of the artery as well as helps in the healing of the artery. It combines the benefit of DES with the benefits of bio-engineered stents and is the only stent to contain a drug with an active healing technology. These types of stents are usually made of metal mesh and are commonly called heart stents or cardiac or coronary stents.
Coronary Stent Grafts Market: Drivers and Restraints
Growing cases of coronary angioplasty (a treatment to widen narrowed sections of coronary arteries) is one of the key factors driving the demand for coronary stent grafts in hospitals, surgical centers and emergency rooms. The growth in the number of patients suffering from angina is leading to growth in demand for coronary angioplasty, which is driving the coronary stent graft market. Besides, due to less surgery time and low cost of surgery as compared to bypass surgery, coronary angioplasty is highly favored. The average cost of the Minimally Invasive Coronary Bypass Surgery in India is approximately $7000 whereas the cost of angioplasty in India for a single stent is around $ 2,745. However, the side effects associated with coronary angioplasty (PCI) might hamper its adoption rate. It has been observed that PCI itself tends to injure the artery walls and increases the risk of secondary obstruction. In fact, 21% of the PCI group required another stent within six months while 60% of the treated vessels required re-stenting. Thus, this factor is expected to restrict the growth of the coronary stent grafts market during the forecast period.
Coronary Stent Grafts Market: Overview
The global market for coronary stent grafts is expected to witness moderate growth over the forecast period. Metal coronary stent grafts are expected to be a dominant segment in the global coronary stent grafts market over the forecast period. Among all different types of coronary stent grafts, bioresorbable vascular scaffold type to hold significant share in the global coronary stent grafts market. The hospitals end-use segment is expected to contribute high share owing to increasing cases of patients suffering from angina.
Coronary Stent Grafts Market: Regional Outlook
Geographically, the global coronary stent grafts market is segmented into the following regions: North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to dominate the global coronary stent grafts market owing to growing number of patients suffering from cardiac or artery related disorders as well as the technological advancements taking place in the coronary stent grafts market. Europe to hold the second largest share in the coronary stent grafts market owing to direct presence of key manufacturers in Western as well as Eastern Europe. However, the market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to gradually increasing patient pool, low surgery cost in Asian countries, medical tourism and growing geographical reach of major players.
Coronary Stent Grafts Market: Key Participants
The global market for coronary stent grafts is a highly consolidated market. This market is specifically dominated by key players, such as Bentley Innomed GmbH, Abbott, Vascular Concepts and InSitu Technologies® Inc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1065
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Stent Grafts Market Emerging Economies Expected to Influence Growth until 2028 // key player - Bentley Innomed GmbH, Abbott, Vascular Concepts, InSitu Technologies here
News-ID: 1687836 • Views: …
More Releases from Fact.MR
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by …
Fact.MR, a market research and competitive intelligence service, states that historically, the use of Agricultural Films grew at a 3.5% CAGR from 2016 to 2020, with the United States, China, India, and Japan holding a sizable portion of the global market. by 2021, the greenhouse film industry is expected to have grown to a valuation of over US$ 10 billion, largely due to price increases in agricultural films.
For More Insights…
Medical Equipment Rental Market is projected to expand at a CAGR of 5.5% to reac …
The latest industry analysis from Fact.MR, a company that offers competitive intelligence and market research, projects that the global Medical Equipment Rental Market will grow at a 5.5% CAGR and reach US$ 98 billion in size by the end of 2033.
The industry that deals with the short-term rental or lease of medical equipment to healthcare facilities, organizations, and individuals is known as the "medical equipment rental market." The goal of…
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
The worldwide craft beer market was expected to be worth $76.3 billion in 2020 and $81.64 billion in 2021. The market will grow at a steady CAGR of 6.9% between 2022 and 2032. By the end of 2032, this market is predicted to have a global valuation of US$174.68 billion.
The surge in demand for more beer styles coupled with increase in per capita income among the target customers has triggered…
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
The global window blinds market is expected to reach $2.99 billion in 2024, growing at a 5.8% CAGR to $4.69 billion by the end of 2034.
Window blinds are adjustable window coverings made of slats or vanes, allowing for versatile control over light and privacy. They come in various materials, including wood, metal, or plastic, and can be easily adjusted to regulate sunlight and maintain privacy. Unlike heavy curtains, blinds are…
More Releases for Stent
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting.
Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,…
Global Coronary Stent Grafts Market to Observe Strong Development during the For …
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still…
